Published in Blood Weekly, May 6th, 2004
The presentation, entitled "Inter-domain disulfide bridge in rFVIII selectively blocks A2- dissociation-dependent loss of FVIIIa activity while preserving sensitivity to inactivation by APC," received the Professor Landbeck award as the second-best abstract submitted to the meeting.
Klaus-Peter Radtke, senior staff scientist at Bayer BP, presented the research at a special symposium honoring the top 10 abstracts....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.